by Susan Buckles – Mayo Clinic –
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to match and susceptible to rejection, Mayo Clinic researchers discovered.
Their pioneering research focuses on using CAR-T cells derived from the patient’s own immune system to prevent rejection of donated organs…
